555 related articles for article (PubMed ID: 18595484)
21. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
Kim HR; Lee SH; Kim HY
Rheumatology (Oxford); 2006 Oct; 45(10):1197-200. PubMed ID: 16567356
[TBL] [Abstract][Full Text] [Related]
22. How should clinicians manage osteoporosis in ankylosing spondylitis?
Bessant R; Keat A
J Rheumatol; 2002 Jul; 29(7):1511-9. PubMed ID: 12136913
[TBL] [Abstract][Full Text] [Related]
23. Comparing morphometric X-ray absorptiometry and radiography in defining vertebral wedge fractures in patients with ankylosing spondylitis.
Vosse D; Heijckmann C; Landewé R; van der Heijde D; van der Linden S; Geusens P
Rheumatology (Oxford); 2007 Nov; 46(11):1667-71. PubMed ID: 17804453
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and risk factors of low bone mineral density in juvenile onset ankylosing spondylitis.
Bao J; Chen Y; Bao YX
Calcif Tissue Int; 2014 Aug; 95(2):108-11. PubMed ID: 24854154
[TBL] [Abstract][Full Text] [Related]
25. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.
Mermerci Başkan B; Pekin Doğan Y; Sivas F; Bodur H; Ozoran K
Rheumatol Int; 2010 Jan; 30(3):375-81. PubMed ID: 19685057
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis.
Ghozlani I; Ghazi M; Nouijai A; Mounach A; Rezqi A; Achemlal L; Bezza A; El Maghraoui A
Bone; 2009 May; 44(5):772-6. PubMed ID: 19442629
[TBL] [Abstract][Full Text] [Related]
27. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
28. Opportunistic computed tomography screening shows a high incidence of osteoporosis in ankylosing spondylitis patients with acute vertebral fractures.
Emohare O; Cagan A; Polly DW; Gertner E
J Clin Densitom; 2015; 18(1):17-21. PubMed ID: 25172008
[TBL] [Abstract][Full Text] [Related]
29. Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study.
van der Weijden MA; van Denderen JC; Lems WF; Nurmohamed MT; Dijkmans BA; van der Horst-Bruinsma IE
J Rheumatol; 2016 Apr; 43(4):758-64. PubMed ID: 26879348
[TBL] [Abstract][Full Text] [Related]
30. Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes.
Karberg K; Zochling J; Sieper J; Felsenberg D; Braun J
J Rheumatol; 2005 Jul; 32(7):1290-8. PubMed ID: 15996067
[TBL] [Abstract][Full Text] [Related]
31. Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.
Rossini M; Viapiana O; Idolazzi L; Ghellere F; Fracassi E; Troplini S; Povino MR; Kunnathully V; Adami S; Gatti D
Calcif Tissue Int; 2016 May; 98(5):438-45. PubMed ID: 26645432
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: a 5-year follow-up study of 504 cases.
Wang DM; Zeng QY; Chen SB; Gong Y; Hou ZD; Xiao ZY
Clin Exp Rheumatol; 2015; 33(4):465-70. PubMed ID: 25962324
[TBL] [Abstract][Full Text] [Related]
33. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis.
Toussirot E; Michel F; Wendling D
Rheumatology (Oxford); 2001 Aug; 40(8):882-8. PubMed ID: 11511757
[TBL] [Abstract][Full Text] [Related]
34. Correlations of dual-energy X-ray absorptiometry, quantitative computed tomography, and single photon absorptiometry with spinal and non-spinal fractures.
Lafferty FW; Rowland DY
Osteoporos Int; 1996; 6(5):407-15. PubMed ID: 8931036
[TBL] [Abstract][Full Text] [Related]
35. Ankylosing spondylitis and bone mineral density--what is the ideal tool for measurement?
Lange U; Kluge A; Strunk J; Teichmann J; Bachmann G
Rheumatol Int; 2005 Dec; 26(2):115-20. PubMed ID: 15538574
[TBL] [Abstract][Full Text] [Related]
36. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.
Arends S; Spoorenberg A; Bruyn GA; Houtman PM; Leijsma MK; Kallenberg CG; Brouwer E; van der Veer E
Osteoporos Int; 2011 May; 22(5):1431-9. PubMed ID: 20603707
[TBL] [Abstract][Full Text] [Related]
37. [Role of osteoporosis in trauma diagnostics].
Bitterling H; Vogel T; Dobler T; Mutschler W; Pfeifer KJ; Reiser M; Eibel R
Rofo; 2005 Dec; 177(12):1663-9. PubMed ID: 16333789
[TBL] [Abstract][Full Text] [Related]
38. Bone tissue metabolism in men with ankylosing spondylitis.
Korczowska I; Przepiera-Bedzak H; Brzosko M; Lacki JK; Trefler J; Hrycaj P
Adv Med Sci; 2011; 56(2):264-9. PubMed ID: 22112431
[TBL] [Abstract][Full Text] [Related]
39. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
[TBL] [Abstract][Full Text] [Related]
40. Bone Mineral Density and Fracture Risk in Ankylosing Spondylitis: A Meta-Analysis.
Pray C; Feroz NI; Nigil Haroon N
Calcif Tissue Int; 2017 Aug; 101(2):182-192. PubMed ID: 28421263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]